|Bid||2.1200 x 800|
|Ask||2.3000 x 2200|
|Day's range||2.1200 - 2.3017|
|52-week range||0.9700 - 7.2000|
|Beta (5Y monthly)||0.63|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript October 31, 2023 Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Third Quarter 2023 Results Conference Call. Before we begin, we want to advise you that over the course of the call and question-and-answer session, forward-looking statements will be made regarding events, trends, […]
After losing some value lately, a hammer chart pattern has been formed for Plus (PSTV), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Plus (PSTV) delivered earnings and revenue surprises of 0% and 68.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?